Open AccessPreventing thrombosis in a COVID‐19 patient by combined therapy with nafamostat and heparin during extracorporeal membrane oxygenation
Author(s) -
Doi Shunichi,
Akashi Yoshihiro J.,
Takita Mumon,
Yoshida Hideki,
Morikawa Daiki,
Ishibashi Yuki,
Higuma Takumi,
Fujitani Shigeki
Publication year - 2020
Publication title -
acute medicine and surgery
Language(s) - English
Resource type - Journals
ISSN - 2052-8817
DOI - 10.1002/ams2.585
Subject(s) - medicine , extracorporeal membrane oxygenation , heparin , thrombosis , venous thrombosis , pneumonia , anesthesia , intensive care medicine , surgery
This report describes a COVID‐19 patient treated with nafamostat and heparin to prevent circuit thrombosis during extracorporeal membrane oxygenation (ECMO) support. Combination with nafamostat and heparin might prevent circuit thrombosis in ECMO.